Peroxisome proliferator-activated receptor coactivator-1α (PGC-1α) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and-γ: identification of novel … JM Huss, RP Kopp, DP Kelly Journal of Biological Chemistry 277 (43), 40265-40274, 2002 | 572 | 2002 |
Survival outcomes after radical and partial nephrectomy for clinical T 2 renal tumours categorised by RENAL nephrometry score RP Kopp, R Mehrazin, KL Palazzi, MA Liss, R Jabaji, HS Mirheydar, ... BJU international 114 (5), 708-718, 2014 | 153 | 2014 |
Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery JL Silberstein, F Millard, R Mehrazin, R Kopp, W Bazzi, CJ DiBlasio, ... BJU international 106 (9), 1270-1276, 2010 | 131 | 2010 |
RENAL nephrometry score is associated with operative approach for partial nephrectomy and urine leak SP Stroup, K Palazzi, RP Kopp, R Mehrazin, M Santomauro, SA Cohen, ... Urology 80 (1), 151-156, 2012 | 104 | 2012 |
HMGB1 expression and release by bone cells K Charoonpatrapong, R Shah, AG Robling, M Alvarez, DW Clapp, S Chen, ... Journal of cellular physiology 207 (2), 480-490, 2006 | 101 | 2006 |
Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008 SP Stroup, K Palazzi‐Churas, RP Kopp, JK Parsons BJU international 109 (1), 84-87, 2012 | 92 | 2012 |
Factors affecting renal function after open partial nephrectomy—a comparison of clampless and clamped warm ischemic technique RP Kopp, R Mehrazin, K Palazzi, WM Bazzi, AL Patterson, IH Derweesh Urology 80 (4), 865-871, 2012 | 74 | 2012 |
Analysis of renal functional outcomes after radical or partial nephrectomy for renal masses≥ 7 cm using the RENAL score RP Kopp, MA Liss, R Mehrazin, S Wang, HJ Lee, R Jabaji, HS Mirheydar, ... Urology 86 (2), 312-320, 2015 | 61 | 2015 |
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12. 2 region as a multi-signal locus associated with bladder cancer risk in individuals of … JD Figueroa, CD Middlebrooks, AR Banday, Y Ye, M Garcia-Closas, ... Human molecular genetics 25 (6), 1203-1214, 2016 | 49 | 2016 |
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study SP Stroup, OA Raheem, KL Palazzi, MA Liss, R Mehrazin, RP Kopp, ... Urology 81 (4), 805-812, 2013 | 47 | 2013 |
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors RP Kopp, LM Marshall, PY Wang, DC Bauer, E Barrett-Connor, ... European urology 64 (4), 672-679, 2013 | 45 | 2013 |
Impact of tumour morphology on renal function decline after partial nephrectomy R Mehrazin, KL Palazzi, RP Kopp, CJ Colangelo, SP Stroup, ... BJU international 111 (8), E374-E382, 2013 | 42 | 2013 |
Comparison of laparoendoscopic single-site and multiport laparoscopic radical and partial nephrectomy: a prospective, nonrandomized study WM Bazzi, SP Stroup, RP Kopp, SA Cohen, K Sakamoto, IH Derweesh Urology 80 (5), 1039-1045, 2012 | 40 | 2012 |
Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source RP Werntz, A Martinez-Acevedo, H Amadi, R Kopp, J La Rochelle, ... Urologic Oncology: Seminars and Original Investigations 36 (5), 238. e1-238. e5, 2018 | 37 | 2018 |
Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions G Bobe, Z Zhang, R Kopp, M Garzotto, J Shannon, Y Takata European Journal of Cancer Prevention 29 (2), 191-200, 2020 | 34 | 2020 |
Obesity and prostate enlargement in men with localized prostate cancer RP Kopp, M Han, AW Partin, E Humphreys, SJ Freedland, JK Parsons BJU international 108 (11), 1750-1755, 2011 | 32 | 2011 |
Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. RP Kopp, L Aganovic, KL Palazzi, FH Cassidy, K Sakamoto, IH Derweesh The Canadian Journal of Urology 20 (3), 6790-6797, 2013 | 25 | 2013 |
Comparison of rates and risk factors for development of anaemia and erythropoiesis‐stimulating agent utilization after radical or partial nephrectomy J Woldrich, R Mehrazin, WM Bazzi, A Bagrodia, RP Kopp, JB Malcolm, ... BJU international 109 (7), 1019-1025, 2012 | 25 | 2012 |
An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality J Sullivan, R Kopp, K Stratton, C Manschreck, M Corines, R Rau-Murthy, ... British journal of cancer 113 (1), 166-172, 2015 | 21 | 2015 |
Partial cystectomy after neoadjuvant chemotherapy: Memorial Sloan Kettering Cancer Center contemporary experience WM Bazzi, RP Kopp, TF Donahue, M Bernstein, P Russo, BH Bochner, ... International Scholarly Research Notices 2014, 2014 | 21 | 2014 |